Goodwin advised Generate:Biomedicines on the fundraising. Generate:Biomedicines announced that it has raised $273 million in Series C financing. This financing round attracted many new investors including...
You must be a Standard 1 Year member to access this content.
Davis Polk advised Sun Pharmaceutical, and Goodwin Procter advised Concert Pharmaceuticals. Sun Pharmaceutical Industries Limited announced its acquisition of Concert Pharmaceuticals Inc., through a tender offer for an...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised WHP Global on the deal, while Kirkland & Ellis advised Express. WHP Global entered into a mutually transformative strategic partnership with Express, Inc. (NYSE:...
You must be a Standard 1 Year member to access this content.
